ß1-Adrenergic receptor blockade extends the life span of Drosophila and long-lived mice

Age

Volumn 35, Issue 6, 2013, Pages 2099-2109

  Spindler, Stephen R ^a   Mote, Patricia L ^a   Li, Rui ^a   Dhahbi, Joseph M ^a   Yamakawa, Amy ^a   Flegal, James M ^b   Jeske, Daniel R ^b   Lublin, Alex L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

blocker; Adrenoceptor; Catecholamine; Epinephrine; Intracellular signaling; Life span; Longevity; Norepinephrine; Octopamine

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; METOPROLOL; NEBIVOLOL; PLACEBO; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; DROSOPHILA; DRUG TARGETING; DRUG TOLERABILITY; ENERGY METABOLISM; EXPERIMENTAL MOUSE; FOOD INTAKE; GENETIC CONSERVATION; LIFE EXTENSION; LOCOMOTION; LONGEVITY; MALE; MOUSE; NONHUMAN; PHYLOGENY; AGING; ANIMAL; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; METABOLISM;

ADRENERGIC BETA-ANTAGONISTS; AGING; ANIMALS; DROSOPHILA; ENERGY METABOLISM; LONGEVITY; MALE; MICE; RECEPTORS, ADRENERGIC, BETA;

EID: 84876525472     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-012-9498-3     Document Type: Article

References (59)

1. Andersson B, Blomstrom-Lundqvist C, Hedner T, Waagstein F (1991) Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. J Am Coll Cardiol 18:1059-1066
2. Antos CL, Frey N, Marx SO, Reiken S, Gaburjakova M, Richardson JA, Marks AR, Olson EN (2001) Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. Circ Res89:997-1004
3. Asai K, Yang GP, Geng YJ, Takagi G, Bishop S, Ishikawa Y, Shannon RP,Wagner TE, Vatner DE, Homcy CJ, Vatner SF (1999) Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G (salpha) mouse. J Clin Invest 104:551-558
4. Bartholomeu JB, Vanzelli AS, Rolim NP, Ferreira JC, Bechara LR, Tanaka LY, Rosa KT, Alves MM, Medeiros A, Mattos KC, Coelho MA, Irigoyen MC, Krieger EM, Krieger JE, Negrao CE, Ramires PR, Guatimosim S, Brum PC (2008)Intracellular mechanisms of specific beta- adrenoceptor antagonists involved in improved cardiac function and survival in a genetic model of heart failure. J Mol Cell Cardiol 45:240-249
5. Baumhakel M, Schlimmer N, Buyukafsar K, Arikan O, Bohm M (2008) Nebivolol, but not metoprolol, improves endothelial function of the corpus cavernosum in apolipoprotein e- knockout mice. J Pharmacol Exp Ther 325:818-823
6. Bristow MR (2000) beta-adrenergic receptor blockade in chronic heart failure. Circulation 101:558-569
7. Celik T, Iyisoy A, Kursaklioglu H, Kardesoglu E, Kilic S, Turhan H, Yilmaz MI, Ozcan O, Yaman H, Isik E, Fici F (2006) Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients. J Hypertens 24:591-596
8. Chung LP, Waterer G, Thompson PJ (2011) Pharmacogenetics of beta2 adrenergic receptor gene polymorphisms, longacting beta-agonists and asthma. Clin Exp Allergy 41:312- 326
9. Daly CJ, McGrath JC (2011) Previously unsuspected widespread cellular and tissue distribution of betaadrenoceptors and its relevance to drug action. Trends Pharmacol Sci 32:219-226
10. Dhahbi JM, Spindler SR (2003) Aging of the liver. In: Aspinall R (ed) Aging of the organs and systems. Kluwer Academic Publisher, Dordrecht, The Netherlands, pp 271-291
11. Dhahbi JM, Tsuchiya T, Kim HJ, Mote PL, Spindler SR (2006) Gene expression and physiologic responses of the heart to the initiation and withdrawal of caloric restriction. J Gerontol A Biol Sci Med Sci 61:218-231
12. Driver CJ, Wallis R, Cosopodiotis G, Ettershank G (1986) Is a fat metabolite the major diet dependent accelerator of aging? Exp Gerontol 21:497-507
13. Du XJ, Gao XM, Wang B, Jennings GL, Woodcock EA, Dart AM (2000) Age-dependent cardiomyopathy and heart failure phenotype in mice overexpressing beta(2)-adrenergic receptors in the heart. Cardiovasc Res 48:448-454
14. Eichhorn EJ, Heesch CM, Barnett JH, Alvarez LG, Fass SM, Grayburn PA, Hatfield BA, Marcoux LG, Malloy CR (1994) Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo- controlled study. J Am Coll Cardiol 24:1310-1320
15. Ellison KE, Gandhi G (2005) Optimising the use of betaadrenoceptor antagonists in coronary artery disease. Drugs 65:787-797
16. Engelhardt S, Hein L, Wiesmann F, Lohse MJ (1999) Progressive hypertrophy and heart failure in beta1- adrenergic receptor transgenic mice. Proc Natl Acad SciU S A 96:7059-7064
17. Entschladen F, Lang K, Drell TL, Joseph J, Zaenker KS (2002) Neurotransmitters are regulators for the migration of tumor cells and leukocytes. Cancer Immunol Immunother 51:467-482
18. Esler M, Kaye D, Lambert G, Esler D, Jennings G (1997) Adrenergic nervous system in heart failure. Am J Cardiol 80:7L-14L
19. Evans PD, Maqueira B (2005) Insect octopamine receptors: A new classification scheme based on studies of cloned Drosophila G-protein coupled receptors. Invert Neurosci 5:111-118
20. Farfel Z, Bourne HR, Iiri T (1999) The expanding spectrum of G protein diseases. N Engl J Med 340:1012-1020
21. Grassi G, Trevano FQ, Facchini A, Toutouzas T, Chanu B, Mancia G (2003) Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial. Blood Press Suppl 2:35-40
22. Ho D, Yan L, Iwatsubo K, Vatner DE, Vatner SF (2010) Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5. Heart Fail Rev 15:495-512
23. Iwase M, Bishop SP, Uechi M, Vatner DE, Shannon RP, Kudej RK, Wight DC, Wagner TE, Ishikawa Y, Homcy CJ, Vatner SF (1996) Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression. Circ Res 78:517-524
24. Ja WW, Carvalho GB, Mak EM, de la Rosa NN, Fang AY, Liong JC, Brummel T, Benzer S (2007) Prandiology of Drosophila and the CAFE assay. Proc Natl Acad Sci U S A 104:8253- 8256
25. Jeske, D. R., Flegal, J., and Spindler, S. R. (2012) Minimum size survival analysis sampling plans for comparing multiple treatment groups t o a single control group. Communications in Statistics-Theory and Methods (in press)
26. Johnson E, Ringo J, Dowse H (1997) Modulation of Drosophila heartbeat by neurotransmitters. J Comp Physiol B 167:89- 97
27. Johnson JA, Terra SG (2002) Beta-adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics. Pharm Res 19:1779-1787
28. Johnson M (2001) Beta2-adrenoceptors: mechanisms of action of beta2-agonists. Paediatr Respir Rev 2:57-62
29. Lakatta EG (1993) Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 73:413- 467
30. Lang K, Drell TL, Lindecke A, Niggemann B, Kaltschmidt C, Zaenker KS, Entschladen F (2004) Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112:231-238
31. Liggett SB, Tepe NM, Lorenz JN, Canning AM, Jantz TD, Mitarai S, Yatani A, Dorn GW (2000) Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101:1707-1714
32. Maqueira B, Chatwin H, Evans PD (2005) Identification and characterization of a novel family of Drosophila betaadrenergic- like octopamine G-protein coupled receptors. J Neurochem 94:547-560
33. Martinez JA, Corbalan MS, Sanchez-Villegas A, Forga L, Marti A, Martinez-Gonzalez MA (2003) Obesity risk is associated with carbohydrate intake in women carrying the Gln27Glu beta2-adrenoceptor polymorphism. J Nutr 133:2549-2554
34. Meinhardt G, Wendtner CM, Hallek M (1999) Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival. J Mol Med (Berl) 77:282-293
35. Min KJ, Tatar M (2006) Drosophila diet restriction in practice: do flies consume fewer nutrients? Mech Ageing Dev 127:93-96
36. National Institutes of Health (1994) Manual of microbiologic monitoring of laboratory animals. NIH p. 151-154
37. Council NR (1991) Infectious diseases of mice and rats. National Academy, Washington, p 397
38. Ohhara Y, Kayashima Y, Hayashi Y, Kobayashi S, Yamakawa- Kobayashi K (2012) Expression of beta-adrenergic-like octopamine receptors during Drosophila development. Zoolog Sci 29:83-89
39. Panchal AR, Stanley WC, Kerner J, Sabbah HN (1998) Betareceptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure. J Card Fail 4:121-126
40. Port JD, Bristow MR (2001) Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol 33:887-905
41. Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659-661
42. Roeder T (1999) Octopamine in invertebrates. Prog Neurobiol 59:533-561
43. Roeder T (2005) Tyramine and octopamine: ruling behavior and metabolism. Annu Rev Entomol 50:447-477
44. Rozec B, Quang TT, Noireaud J, Gauthier C (2006) Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta. Br J Pharmacol 147:699-706
45. Sacco G, Evangelista S, Manzini S, Parlani M, Bigioni M (2011) Combined antihypertensive and cardioprotective effects of nebivolol and hydrochlorothiazide in spontaneous hypertensive rats. Future Cardiol 7:757-763
46. Sastry KS, Karpova Y, Prokopovich S, Smith AJ, Essau B, Gersappe A, Carson JP, Weber MJ, Register TC, Chen YQ, Penn RB, Kulik G (2007) Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation. J Biol Chem 282:14094-14100
47. Shang ZJ, Liu K, Liang DF (2009) Expression of beta2- adrenergic receptor in oral squamous cell carcinoma. J Oral Pathol Med 38:371-376
48. Sharma V, McNeill JH (2011) Parallel effects of betaadrenoceptor blockade on cardiac function and fatty acid oxidation in the diabetic heart: confronting the maze. World J Cardiol 3:281-302
49. Sheldon WG, Bucci TJ, Hart RW, Turturro A (1995) Agerelated neoplasia in a lifetime study of ad libitum-fed and food-restricted B6C3F1 mice. Toxicol Pathol 23:458-476
50. Sorrentino SA, Doerries C, Manes C, Speer T, Dessy C, Lobysheva I, Mohmand W, Akbar R, Bahlmann F, Besler C, Schaefer A, Hilfiker-Kleiner D, Luscher TF, Balligand JL, Drexler H, Landmesser U (2011) Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells,myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional beta1-blockade. J Am Coll Cardiol 57:601-611
51. Spindler SR (2012) Review of the literature and suggestions for the design of rodent survival studies for the identification of compounds that increase health and life span. Age (Dordr) 34:111-120
52. Spindler SR, Li R, Dhahbi JM, Yamakawa A, Mote P, Bodmer R, Ocorr K, Williams RT, Wang Y, Ablao KP (2012a) Statin treatment increases lifespan and improves cardiac health in Drosophila by decreasing specific protein prenylation. PLoS One 7:e39581
53. Spindler SR, Li R, Dhahbi JM, Yamakawa A, Sauer F (2012b) Novel protein kinase signaling systems regulating lifespan identified by small molecule library screening using Drosophila. PLoS One 7:e29782
54. Swynghedauw B, Besse S, Assayag P, Carre F, Chevalier B, Charlemagne D, Delcayre C, Hardouin S, Heymes C, Moalic JM (1995) Molecular and cellular biology of the senescent hypertrophied and failing heart. Am J Cardiol 76:2D-7D
55. Taylor MR, Bristow MR (2004) The emerging pharmacogenomics of the beta-adrenergic receptors. Congest Heart Fail 10:281-288
56. Wang H, Hao B, Chen X, Zhao N, Cheng G, Jiang Y, Liu Y, Lin C, Tan W, Lu D, Wei Q, Jin L, Lin D, He F (2006) Beta-2 adrenergic receptor gene (ADRB2) polymorphism and risk for lung adenocarcinoma: A case-control study in a Chinese population. Cancer Lett 240:297-305
57. Yan L, Vatner DE, O'Connor JP, Ivessa A, Ge H, Chen W, Hirotani S, Ishikawa Y, Sadoshima J, Vatner SF (2007) Type 5 adenylyl cyclase disruption increases longevity and protects against stress. Cell 130:247-258
58. Zhao L, Yang FXK, Cao H, Zheng G, Zhang Y, Li J, Cui H, Chen X, Zhu Z, He H,Mo X, ennedy BK, Suh Y, Zeng Y, Tian X (2012) Common genetic variants of the â2-adrenergic receptor affect its translational efficiency and are associated with human longevity. Aging Cell. doi:10.1111/acel.12011
59. Zornik E, Paisley K, Nichols R (1999) Neural transmitters and a peptide modulate Drosophila heart rate. Peptides 20:45-51